Yet treatment guidelines have offered no clear direction for choosing between these two leading drug classes, leaving clinicians to make high-stakes decisions on thin evidence
The potential market could cross 5,000 crore, driven by Indias obesity burden
At Boost Health Clinic, our physicians specialize in helping men lose weight, reclaim energy, and optimize their hormones through evidence-based GLP-1 medications and comprehensive metabolic health programs
But it will take some time before it's completely out of the market, and we have a fair chance of regaining our fair share (of the market)." And yet, as of 2026, compounded GLP-1s dont appear to be going anywhere
[10] It is also linked with anxiety, high blood pressure, rapid heartbeat, and insomnia
With hormones in decline during menopause, which leads to muscle and bone loss, a weighted vest can help build muscle